参考文献/References:
[1] Benjamin EJ,Muntner P,Alonso A,et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association[J]. Circulation,2019,139(10):e56-e528.
[2] Timmis A,Townsend N,Gale CP,et al. European Society of Cardiology: cardiovascular disease statistics 2019[J]. Eur Heart J,2020,41(1):12-85.
[3] Berry C,Corcoran D,Hennigan B,et al. Fractional flow reserve-guided management in stable coronary disease and acute myocardial infarction: recent developments[J]. Eur Heart J,2015,36(45):3155-3164.
[4] Pothineni NV,Shah NN,Rochlani Y,et al. U.S. trends in inpatient utilization of fractional flow reserve and percutaneous coronary intervention[J]. J Am Coll Cardiol,2016,67(6):732-733.
[5] Morris PD,van de Vosse FN,Lawford PV,et al. "Virtual" (computed) fractional flow reserve: current challenges and limitations[J]. JACC Cardiovasc Interv,2015,8(8):1009-1017.
[6] Pijls NHJ,Fearon WF,Tonino PAL,et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study[J]. J Am Coll Cardiol,2010,56(3):177-184.
[7] Sels JW,Tonino PA,Siebert U,et al. Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study[J]. JACC Cardiovasc Interv,2011,4(11):1183-1189.
[8] Layland J,Oldroyd KG,Curzen N,et al. Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial[J]. Eur Heart J,2015,36(2):100-111.
[9] Fearon WF,Nishi T,De Bruyne B,et al. Clinical outcomes and cost-effectiveness of fractional flow reserve-guided percutaneous coronary intervention in patients with stable coronary artery disease: three-year follow-up of the FAME 2 trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation)[J]. Circulation,2018,137(5):480-487.
[10] Ahmadi A,Stanger D,Puskas J,et al. Is there a role for fractional flow reserve in coronary artery bypass graft (CABG) planning?[J]. Ann Cardiothorac Surg,2018,7(4):546-551.
[11] Zimmermann FM,Ferrara A,Johnson NP,et al. Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial[J]. Eur Heart J,2015,36(45):3182-3188.
[12] Xaplanteris P,Fournier S,Pijls NHJ,et al. Five-year outcomes with PCI guided by fractional flow reserve[J]. N Engl J Med,2018,379(3):250-259.
[13] Ritsinger V,Saleh N,Lagerqvist B,et al. High event rate after a first percutaneous coronary intervention in patients with diabetes mellitus: results from the Swedish coronary angiography and angioplasty registry[J]. Circ Cardiovasc Interv,2015,8(6):e002328.
[14] Pijls NH,De Bruyne B,Peels K,et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses[J]. N Engl J Med,1996,334(26):1703-1708.
[15] Domínguez-Franco AJ,Jiménez-Navarro MF,Mu?oz-García AJ,et al. Long-term prognosis in diabetic patients in whom revascularization is deferred following fractional flow reserve assessment[J]. Rev Esp Cardiol,2008,61(4):352-359.
[16] Kennedy MW,Kaplan E,Hermanides RS,et al. Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitus[J]. Cardiovasc Diabetol,2016,15:100.
[17] Liu Z,Matsuzawa Y,Herrmann J,et al. Relation between fractional flow reserve value of coronary lesions with deferred revascularization and cardiovascular outcomes in non-diabetic and diabetic patients[J]. Int J Cardiol,2016,219:56-62.
[18] Alkhalil M,McCune C,McClenaghan L,et al. Clinical outcomes of deferred revascularisation using fractional flow reserve in diabetic patients[J]. Cardiovasc Revasc Med,2020,21(7)897-902.
[19] Investigators D-FT,Lee JM,Choi KH,et al. Comparison of major adverse cardiac events between instantaneous wave-free ratio and fractional flow reserve-guided strategy in patients with or without type 2 diabetes: a secondary analysis of a randomized clinical trial[J]. JAMA Cardiol,2019,4(9):857-864.
[20] Sarnak MJ,Levey AS,Schoolwerth AC,et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention[J]. Circulation,2003,108(17):2154-2169.
[21] Collins AJ,Kasiske B,Herzog C,et al. Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States[J]. Am J Kidney Dis,2005,45(1 Suppl 1):A5-7, S1-280.
[22] Miyagi N,Arai H. What is optimal revascularization for hemodialysis patients?[J]. Circ J,2012,76(5):1085-1086.
[23] Hirose K,Chikamori T,Hida S,et al. Application of pressure-derived myocardial fractional flow reserve in chronic hemodialysis patients[J]. J Cardiol,2018,71(1):52-58.
[24] Kuramitsu S,Matsuo H,Shinozaki T,et al. Two-year outcomes after deferral of revascularization based on fractional flow reserve: the J-CONFIRM Registry[J]. Circ Cardiovasc Interv,2020,13(1):e008355.
[25] Reardon MJ,van Mieghem NM,Popma JJ,et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients[J]. N Engl J Med,2017,376(14):1321-1331.
[26] Scarsini R,Pesarini G,Zivelonghi C,et al. Physiologic evaluation of coronary lesions using instantaneous wave-free ratio (iFR) in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation[J]. EuroIntervention,2018,13(13):1512-1519.
[27] Scarsini R,Pesarini G,Zivelonghi C,et al. Coronary physiology in patients with severe aortic stenosis: Comparison between fractional flow reserve and instantaneous wave-free ratio[J]. Int J Cardiol,2017,243:40-46.
[28] Zivelonghi C,Pesarini G,Scarsini R,et al. Coronary catheterization and percutaneous interventions after transcatheter aortic valve implantation[J]. Am J Cardiol,2017,120(4):625-631.
[29] Lunardi M,Scarsini R,Venturi G,et al. Physiological versus angiographic guidance for myocardial revascularization in patients undergoing transcatheter aortic valve implantation[J]. J Am Heart Assoc,2019,8(22):e012618.
[30] Gowda RM,Vasavada BC,Khan IA. Coronary artery fistulas: clinical and therapeutic considerations[J]. Int J Cardiol,2006,107(1):7-10.
[31] Huang Z,Liu Z,Ye S. The role of the fractional flow reserve in the coronary steal phenomenon evaluation caused by the coronary-pulmonary fistulas: case report and review of the literature[J]. J Cardiothorac Surg,2020,15(1):32.
[32] Huang AL,Maggiore PL,Brown RA,et al. CT-derived fractional flow reserve (FFRCT): from gatekeeping to roadmapping[J]. Can Assoc Radiol J,2020,71(2):201-207.
[33] Donnelly PM,Kolossváry M,Karády J,et al. Experience with an on-site coronary computed tomography-derived fractional flow reserve algorithm for the assessment of intermediate coronary stenoses[J]. Am J Cardiol,2018,121(1):9-13.
[34] Coenen A,Kim YH,Kruk M,et al. Diagnostic accuracy of a machine-learning approach to coronary computed tomographic angiography-based fractional flow reserve: result from the MACHINE consortium[J]. Circ Cardiovasc Imaging,2018,11(6):e007217.
[35] Cook CM,Petraco R,Shun-Shin MJ,et al. Diagnostic accuracy of computed tomography-derived fractional flow reserve:a systematic review[J]. JAMA Cardiol,2017,2(7):803-810.
[36] Fairbairn TA,Nieman K,Akasaka T,et al. Real-world clinical utility and impact on clinical decision-making of coronary computed tomography angiography-derived fractional flow reserve: lessons from the ADVANCE Registry[J]. Eur Heart J,2018,39(41):3701-3711.
[37] Jensen JM,B?tker HE,Mathiassen ON,et al. Computed tomography derived fractional flow reserve testing in stable patients with typical angina pectoris: influence on downstream rate of invasive coronary angiography[J]. Eur Heart J Cardiovasc Imaging,2018,19(4):405-414.
[38] Tu S,Westra J,Yang J,et al. Diagnostic accuracy of fast computational approaches to derive?fractional flow reserve from?diagnostic coronary angiography: the international multicenter FAVOR pilot study[J]. JACC Cardiovasc Interv,2016,9(19):2024-2035.
[39] Xu B,Tu S,Qiao S,et al. Diagnostic accuracy of angiography-based quantitative flow?ratio measurements for online assessment?of coronary stenosis[J]. J Am Coll Cardiol,2017,70(25):3077-3087.
相似文献/References:
[1]刘凡 杨树森.血流储备分数指导冠状动脉再血管化的相关进展[J].心血管病学进展,2019,(5):797.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.033]
LIU FanYANG Shusen.The Relevant Grogress of FFR-Guided Coronary Revascularization[J].Advances in Cardiovascular Diseases,2019,(12):797.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.033]
[2]杨金凤,贾辛未,冯惠平,等.血流储备分数用于评估心肌桥及其合并临界狭窄病变的研究现状[J].心血管病学进展,2020,(3):313.[doi:10.16806/j.cnki.issn.1004-3934.20.03.024]
YANG Jinfeng,JIA Xinwei,FENG Huiping,et al.Current Status of Fractional Flow Reserve for Evaluation of Myocardial Bridge and Its Associated Critical Stenosis[J].Advances in Cardiovascular Diseases,2020,(12):313.[doi:10.16806/j.cnki.issn.1004-3934.20.03.024]
[3]杨金凤,贾辛未,唐伟,等.冠状动脉血流储备分数指导下的心肌桥合并近端临界狭窄病变介入治疗疗效观察[J].心血管病学进展,2020,(3):317.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.025]
YANG Jinfeng,JIA Xinwei,TANG Wei,et al.Therapeutic Effect of Percutaneous Coronary Intervention for Myocardial Bridge Combined Proximal Borderline Stenosis under Guidance of Fractional Flow Reserve[J].Advances in Cardiovascular Diseases,2020,(12):317.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.025]
[4]栗竞 单冬凯 王凡.基于冠状动脉CT血管造影的功能学评价技术[J].心血管病学进展,2020,(8):812.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.008]
LI JingSHAN DongkaiWANG Fan.Functional Evaluation Technology Based on Coronary CT Angiography[J].Advances in Cardiovascular Diseases,2020,(12):812.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.008]
[5]穆 玥 洪 叶 韩婷婷 黄明刚.冠状动脉CT血管造影评估冠状动脉功能性狭窄的研究进展[J].心血管病学进展,2021,(3):211.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.005]
(.Xian Medical College,Xian 7008,Shaanxi,et al.Coronary Computed Tomography Angiography in Evaluation on Coronary Artery Functional Stenosis[J].Advances in Cardiovascular Diseases,2021,(12):211.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.005]
[6]方舟 羊镇宇.定量血流分数的临床应用及研究进展[J].心血管病学进展,2021,(3):262.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.017]
FANG ZhouYANG Zhenyu.Clinical Application and Research Progress of Quantitative Flow Ratio[J].Advances in Cardiovascular Diseases,2021,(12):262.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.017]
[7]胥日,羊镇宇.冠状动脉非阻塞性心肌梗死的发病机制[J].心血管病学进展,2021,(2):148.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.014]
XU Ri,YANG Zhenyu.Pathogenesis and Imaging Manifestations of Myocardial Infarction with Non-obstructive Coronary Arteries[J].Advances in Cardiovascular Diseases,2021,(12):148.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.014]
[8]李宸 徐少华 陆丽洁 史雨清 龙明智.基于冠状动脉CT血管成像的无创血流储备分数的研究进展[J].心血管病学进展,2021,(5):445.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.015]
Noninvasive Fractional Flow Reserve Derived from Coronary CT Angiography.[J].Advances in Cardiovascular Diseases,2021,(12):445.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.015]
[9]方杰 李春梅 林薿 苏叶 陈丽君 李爽 邓燕 尹立雪 吴志霞.心肌增强多巴酚丁胺负荷超声心动图定量评价冠心病心肌灌注的临床研究[J].心血管病学进展,2021,(8):742.[doi:10.16806/j.cnki.issn.1004-3934.2021.08.017]
FANG Jie,LI Chunmei,LIN Ni,et al.Quantitative Evaluation of Myocardial Perfusion in Coronary Heart Disease by Myocardial Contrast and Dobutamine Stress Echocardiography[J].Advances in Cardiovascular Diseases,2021,(12):742.[doi:10.16806/j.cnki.issn.1004-3934.2021.08.017]
[10]赵润涛 王凡 单冬凯 杨俊杰.CT心肌灌注概述及临床应用进展[J].心血管病学进展,2021,(12):1101.[doi:10.16806/j.cnki.issn.1004-3934.2021.12.011]
ZHAO Runtao WANG Fan SHAN Dongkai?YANG Junjie.CT Myocardial Perfusion and Clinical Application[J].Advances in Cardiovascular Diseases,2021,(12):1101.[doi:10.16806/j.cnki.issn.1004-3934.2021.12.011]